Finance

Lists
DVA:NYSE
Davita Inc
181,78 $
+1,41%
(+2,53) 1D
181,78 $
0,00% (0,00)
After hours
Closed: 12 қаз., 16:00:07 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DVA...
Open
179,61 $
High
182,24 $
Low
179,36 $
Mkt. cap
11,60 млрд
Avg. vol.
654,99 м.
Volume
571,46 м.
P/E ratio
14,89
52-wk high
247,49 $
52-wk low
101,00 $
EPS
12,21 $
Beta
0,80
Shares outstanding
63,80 млн
No. of employees
78 мың
Open
179,61 $
High
182,24 $
Low
179,36 $
Mkt. cap
11,60 млрд
Avg. vol.
654,99 м.
Volume
571,46 м.
P/E ratio
14,89
52-wk high
247,49 $
52-wk low
101,00 $
EPS
12,21 $
Beta
0,80
Shares outstanding
63,80 млн
No. of employees
78 мың
News stories
From web sources and news partners
Profile
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500. Wikipedia
About Davita Inc
CEOJavier J. Rodriguez
Employees78 мың
Founded1992
HeadquartersДенвер, Колорадо, Америка Құрама Штаттары
SectorHealth care provider
Websitedavita.com
Analyst ratings
Based on 5 analysts giving stock ratings to DVA in the past 3 months
Hold
Buy
2
Hold
2
Sell
1
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for DVA in the last 3 months.
Highest
Current 181,78 $
265,00 $ (+45,78%)
Average
231,00 $ (+27,08%)
Lowest
215,00 $ (+18,27%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrew Mok CFA
Barclays
Hold
Maintained
224,00 $
+23,2%
10/07/2026
David S Macdonald
Truist Financial
Hold
Maintained
215,00 $
+18,3%
08/11/2026
Ryan Langston
TD Cowen
Buy
Upgraded
220,00 $
+21%
08/07/2026
Pito Chickering
Deutsche Bank
Buy
Reiterated
265,00 $
+45,8%
08/05/2026
Kevin Fischbeck
Bank of America Securities
Sell
Reiterated
-
-
08/05/2026
A.J. Rice
UBS
Buy
Reiterated
270,00 $
+48,5%
07/10/2026
Last report
2026 ж. 04 там.
Fiscal period
Q2 2026
4,02 $ / 3,88 $
+3,55%beat
Revenue / Est. (USD)
3,55 млрд / 3,49 млрд
+1,73%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
3,42 млрд
3,62 млрд
3,42 млрд
3,55 млрд
Cost of goods sold
2,33 млрд
2,41 млрд
2,34 млрд
2,39 млрд
Cost of revenue
2,33 млрд
2,41 млрд
2,34 млрд
2,39 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
402,67 млн
472,36 млн
421,91 млн
423,46 млн
Operating expense
580,16 млн
659,06 млн
599,74 млн
591,27 млн
Total operating expenses
2,91 млрд
3,07 млрд
2,94 млрд
2,98 млрд
Operating income
507,30 млн
551,20 млн
473,55 млн
570,82 млн
Other non operating income
-17,26 млн
-21,03 млн
639,00 м.
4,47 млн
EBT including unusual items
308,80 млн
382,76 млн
341,23 млн
435,01 млн
EBT excluding unusual items
351,55 млн
391,79 млн
341,23 млн
437,04 млн
Income tax expense
68,55 млн
76,73 млн
66,20 млн
91,79 млн
Effective tax rate
22,20%
20,05%
19,40%
21,10%
Other operating expenses
-
-
-
-
Net income
150,33 млн
234,22 млн
197,53 млн
265,40 млн
Net profit margin
4,40%
6,47%
5,78%
7,47%
Earnings per share
2,51
3,40
2,87
4,02
Interest and investment income
-
-
-
-
Interest expense
-148,66 млн
-148,25 млн
-141,30 млн
-146,42 млн
Net interest expenses
-148,66 млн
-148,25 млн
-141,30 млн
-146,42 млн
Depreciation and amortization charges
177,49 млн
186,70 млн
177,83 млн
167,81 млн
EBITDA
684,80 млн
737,91 млн
651,38 млн
738,62 млн
Gain or loss from assets sale
-
-17,55 млн
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары